News & Articles

Results per page

3 Articles Found | Selected Filters:

BioNTech AG Clear Filters

Product NewsLife Sciences

Novel Diagnostic Test Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Cancer

New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission

3 Dec 2018

Product NewsClinical Diagnostics

MammaTyper® Enables More Precise Prediction of the Response to Neoadjuvant Chemotherapy Compared to Manual or Digitalized IHC

First comparison of a biomarker analysis by RT-qPCR (MammaTyper®) versus visual or computer-assisted immunohistochemistry (IHC) in subtyping mammary carcinomas

22 Feb 2017

Product NewsLife Sciences

Precise Quantitative Biomarker Detection for Molecular Breast Cancer Subtyping

Study confirms advantages of the in vitro diagnostic test kit MammaTyper® over immunohistochemistry

16 Jun 2016

News & Articles

Results per page

Articles Filter

Field

Technique

Company

Type of Content

3 Articles Found | Selected Filters:

Novel Diagnostic Test Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Cancer

MammaTyper® Enables More Precise Prediction of the Response to Neoadjuvant Chemotherapy Compared to Manual or Digitalized IHC

Precise Quantitative Biomarker Detection for Molecular Breast Cancer Subtyping

News & Articles

Results per page

Articles FilterArticles Filter

Field

Technique

Company

Type of Content

3 Articles Found | Selected Filters:

Novel Diagnostic Test Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Cancer

MammaTyper® Enables More Precise Prediction of the Response to Neoadjuvant Chemotherapy Compared to Manual or Digitalized IHC

Precise Quantitative Biomarker Detection for Molecular Breast Cancer Subtyping

Articles Filter